Avyansh Formulations Private Limited

Avyansh Formulations Private Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
CIN U24290GJ2022PTC136292 Incorporated 19 October 2022 ROC Ahmedabad HQ Vadodara, Gujarat, India
Active Private Limited Company pharma MSME
Data last updated
Revenue · FY 2025
₹37.48 Cr
▲ 123% YoY
Net profit · FY 2025
₹56.31 Lakh
Net margin 1.5%
EBITDA · FY 2025
₹1.19 Cr
EBITDA margin 3.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹8.15 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Employees · EPFO
10
Provident fund records

About Avyansh Formulations Private Limited

Data last updated:

Avyansh Formulations Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 October 2022.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24290GJ2022PTC136292.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Chandrikaben Vishnubhai Patel and Jay Chaturbhai Butani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop 1 Lifeline Complex Shiyapura Raopura, Vadodara, Gujarat, India – 390001.

As per the financials filed for FY 2025, the company reported a revenue of ₹37.48 Cr, a growth of 123% compared to the previous year. For the same year it recorded a net profit of ₹56.31 Lakh (net margin 1.5%) and EBITDA of ₹1.19 Cr (EBITDA margin 3.2%).

The company has about 10 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹8.15 Cr on record.

Avyansh Formulations Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-17-0007235).

Company details

CIN U24290GJ2022PTC136292
Registration Number 136292
Incorporation Date 19 October 2022
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-GJ-17-0007235

Recognitions & Rankings of Avyansh Formulations

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-GJ-17-0007235

Contact details

Avyansh Formulations Private Limited's registered office is in Vadodara, Gujarat. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Shop 1 Lifeline Complex Shiyapura Raopura, Vadodara, Gujarat, India – 390001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Avyansh Formulations Private Limited, buy the company report.

Comprehensive company report
Avyansh Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Avyansh Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Avyansh Formulations Private Limited, buy the company report.

Financials of Avyansh Formulations Private Limited

FY 2025 filings available

Avyansh Formulations Private Limited reported revenue of ₹37.48 Cr (up 123% YoY) for FY 2025.

Revenue · FY 2025
₹37.48 Cr ▲ 123%
Net profit · FY 2025
₹56.31 Lakh margin 1.5%
EBITDA · FY 2025
₹1.19 Cr margin 3.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 123%
EBITDA CAGR growth
1 year
▼ 13%

Revenue rose 123% in the latest year. EBITDA fell 13% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.19 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹56.31 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin3.2%
Net Profit Margin1.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Avyansh Formulations Private Limited, buy the company report.

Board of directors of Avyansh Formulations Private Limited

Avyansh Formulations has 5 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Chandrikaben Vishnubhai PatelDirector19 Oct 20224 Years 0 MonthsCurrent
Jay Chaturbhai ButaniDirector19 Oct 20224 Years 0 MonthsCurrent
Mitenkumar Ashokbhai ShahDirector19 Oct 20224 Years 0 MonthsCurrent
Nirajkumar Ashokkumar ShahDirector19 Oct 20224 Years 0 MonthsCurrent
Yatinkumar Vishnubhai PatelDirector19 Oct 20224 Years 0 MonthsCurrent

Peer comparison

Avyansh Formulations Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
VVR Organics Private Limited₹38.01 Cr (FY 2024)9.0%Hyderabad, Telangana, India
Purogene Labs Private Limited₹37.79 Cr (FY 2025)36.0%Hyderabad, Telangana, India
Ivpex Parenteral Private Limited₹37.61 Cr (FY 2025)5.0%Baddi, Himachal Pradesh, India
Titanium Technologies (India) Private Limited₹37.49 Cr (FY 2024)60.0%New Delhi, Delhi, India
Avyansh Formulations Private Limitedthis company₹37.48 Cr (FY 2025)₹56.31 Lakh1.5%123.0%Vadodara, Gujarat, India
Garima Healthcare Private Limited₹37.46 Cr (FY 2025)15.0%Indore, Madhya Pradesh, India
Raut Serums India Private Limited₹37.44 Cr (FY 2025)35.0%Pune, Maharashtra, India
Savvy Care & Cosmetics Private Limited₹37.12 Cr (FY 2024)25.0%Navi Mumbai, Maharashtra, India

To see the full peer comparison of Avyansh Formulations Private Limited, buy the company report.

Auditor

Avyansh Formulations Private Limited is audited by Manish Dubal & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Manish Dubal & AssociatesFY 2023123305

Shareholding

The shareholding of Avyansh Formulations Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Avyansh Formulations Private Limited, buy the company report.

Charges & borrowings

Open charges
₹8.15 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹8.15 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Jan 2023100667751Others₹4 CrOpen
24 Jan 2023100668949Others₹15 LakhOpen
04 Jan 2023100667974Others₹4 CrOpen

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Avyansh Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Avyansh Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Avyansh Formulations Private Limited has 5 board changes on record since 2022: 5 appointments. The latest: Chandrikaben Vishnubhai Patel was appointed as Director on 19 Oct 2022.

AGM
Avyansh Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Avyansh Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 400.00 Lakh with Charge ID 100667751 was registered on 24 Jan 2023.
Charges
A charge with Others amounted to Rs. 15.00 Lakh with Charge ID 100668949 was registered on 24 Jan 2023.
Charges
A charge with Others amounted to Rs. 400.00 Lakh with Charge ID 100667974 was registered on 04 Jan 2023.
Appointed
Chandrikaben Vishnubhai Patel was appointed as Director.
Appointed
Jay Chaturbhai Butani was appointed as Director.
Appointed
Mitenkumar Ashokbhai Shah was appointed as Director.
Appointed
Nirajkumar Ashokkumar Shah was appointed as Director.
Appointed
Yatinkumar Vishnubhai Patel was appointed as Director.
Incorporation
19 Oct 2022
Avyansh Formulations Private Limited was registered on 19 Oct 2022 with Roc Ahmedabad & aged 4 years 16 days as per MCA records.

Frequently asked questions

Avyansh Formulations is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 October 2022 (4+ years old) and is registered under CIN U24290GJ2022PTC136292.

Avyansh Formulations has 5 current directors:

The latest financial statements of Avyansh Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Avyansh Formulations is U24290GJ2022PTC136292. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Avyansh Formulations was incorporated on 19 October 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Avyansh Formulations by revenue are VVR Organics Private Limited, Purogene Labs Private Limited, Ivpex Parenteral Private Limited, Titanium Technologies (India) Private Limited, Garima Healthcare Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Chandrikaben Vishnubhai Patel was appointed as Director on 19 Oct 2022. Jay Chaturbhai Butani was appointed as Director on 19 Oct 2022. Mitenkumar Ashokbhai Shah was appointed as Director on 19 Oct 2022. Avyansh Formulations has 5 board changes on record in total.

Yes, Avyansh Formulations is registered as an MSME under Udyam registration (number: UDYAM-GJ-17-0007235).

The registered office of Avyansh Formulations is at Shop 1 Lifeline Complex Shiyapura Raopura, Vadodara, Gujarat, India – 390001.

Avyansh Formulations operates in the pharma industry, in the drug formulation and development segment.

Avyansh Formulations has open charges of ₹8.15 Cr and no satisfied charges on record as per latest MCA filings.